0.50Open1.30Pre Close1 Volume38 Open Interest17.50Strike Price50.00Turnover42.61%IV6.51%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier23DDays to Expiry0.50Extrinsic Value100Contract SizeAmericanOptions Type0.4047Delta0.2113Gamma33.80Leverage Ratio-0.0159Theta0.0041Rho13.68Eff Leverage0.0167Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet